Amgen’s Arleen Paulino reports 4,455 directly held shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Amgen Inc. EVP, Operations Arleen Paulino reported 4,455 directly held common shares, including 2,181 restricted stock units and 66 dividend equivalents, plus 2,039.9774 shares represented by interests in the company’s stock fund through the 401(k) Plan. Her report also lists non-qualified stock options, including 5,314 options at a $236.36 exercise price, vested and exercisable, and 7,166 options at $235.97, of which 4,729 are vested. The first tranche expires May 5, 2030; the latter expires May 2, 2033, with its remaining options scheduled to vest and become exercisable on May 2, 2027. Other listed tranches have differing exercise prices and vesting schedules, including installments beginning in 2027.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | Nqso (Right to Buy) F4 | -- | -- | -- |
| Holding | Nqso (Right to Buy) F5 | -- | -- | -- |
| Holding | Nqso (Right to Buy) F6 | -- | -- | -- |
| Holding | Nqso (Right to Buy) F7 | -- | -- | -- |
| Holding | Nqso (Right to Buy) F8 | -- | -- | -- |
| Holding | Nqso (Right to Buy) F9 | -- | -- | -- |
| Holding | Nqso (Right to Buy) F10 | -- | -- | -- |
| Holding | Nqso (Right to Buy) F11 | -- | -- | -- |
| Holding | Common Stock F1, F2 | -- | -- | -- |
| Holding | Common Stock F3 | -- | -- | -- |
Footnotes (11)
- F1. These shares include 2,181 Restricted Stock Units (RSUs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan). Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
- F2. These shares include 66 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
- F3. These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.
- F4. 5,314 of these non-qualified stock options have vested and are exercisable.
- F5. 5,434 of these non-qualified stock options have vested and are exercisable.
- F6. 40,595 of these non-qualified stock options have vested and are exercisable.
- F7. 7,070 of these non-qualified stock options have vested and are exercisable.
- F8. 4,729 of these non-qualified stock options have vested and the remaining options will vest and become exercisable on 5/2/2027.
- F9. 1,427 of these non-qualified stock options have vested and the remaining options will vest and become exercisable in two annual installments, commencing on 5/7/2027.
- F10. 1,553 of these non-qualified stock options have vested and the remaining options will vest and become exercisable in three annual installments, commencing on 5/6/2027.
- F11. These non-qualified stock options will vest and become exercisable in four equal annual installments of 25% each, commencing on 5/5/2027.
Key Figures
Key Terms
non-qualified stock options financial
Restricted Stock Units (RSUs) financial
Dividend Equivalents (DEs) financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What vesting schedules did Arleen Paulino report for AMGN options?
AI-generated analysis. How Rhea-AI works. Not financial advice.